Wilson Hu

719 total citations · 1 hit paper
8 papers, 557 citations indexed

About

Wilson Hu is a scholar working on Epidemiology, Hematology and Genetics. According to data from OpenAlex, Wilson Hu has authored 8 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in Wilson Hu's work include Influenza Virus Research Studies (4 papers), Respiratory viral infections research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Wilson Hu is often cited by papers focused on Influenza Virus Research Studies (4 papers), Respiratory viral infections research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Wilson Hu collaborates with scholars based in United States, Australia and Switzerland. Wilson Hu's co-authors include Günter Härtel, Michael H. Lai, Michael E. Greenberg, Charmaine Gittleson, Christine H. Wichems, Jillian Bennet, Russell L. Basser, Robert A. Livingston, Ruben A. Mesa and Srđan Verstovšek and has published in prestigious journals such as New England Journal of Medicine, Cancer and Vaccine.

In The Last Decade

Wilson Hu

8 papers receiving 540 citations

Hit Papers

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine 2009 2026 2014 2020 2009 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wilson Hu United States 7 456 173 127 70 68 8 557
Laszlo Palkonyay Switzerland 11 255 0.6× 127 0.7× 54 0.4× 42 0.6× 26 0.4× 15 397
G.F. Rimmelzwaan Netherlands 9 289 0.6× 154 0.9× 93 0.7× 117 1.7× 15 0.2× 17 427
Xin Tong China 13 118 0.3× 373 2.2× 90 0.7× 16 0.2× 58 0.9× 32 607
Lynette Phillips United States 7 369 0.8× 141 0.8× 61 0.5× 5 0.1× 27 0.4× 17 537
Sophie Simon France 9 119 0.3× 106 0.6× 41 0.3× 18 0.3× 16 0.2× 18 315
Josefina García Peru 14 366 0.8× 285 1.6× 34 0.3× 34 0.5× 59 0.9× 23 646
Maria R. Farcet Austria 16 137 0.3× 487 2.8× 114 0.9× 8 0.1× 15 0.2× 37 676
Rajeka Lazarus United Kingdom 11 329 0.7× 84 0.5× 82 0.6× 7 0.1× 18 0.3× 24 643
H C Rümke Netherlands 6 92 0.2× 118 0.7× 108 0.9× 26 0.4× 9 0.1× 10 334
Marina Stukova Russia 13 329 0.7× 266 1.5× 173 1.4× 36 0.5× 17 0.3× 66 534

Countries citing papers authored by Wilson Hu

Since Specialization
Citations

This map shows the geographic impact of Wilson Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilson Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilson Hu more than expected).

Fields of papers citing papers by Wilson Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilson Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilson Hu. The network helps show where Wilson Hu may publish in the future.

Co-authorship network of co-authors of Wilson Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Wilson Hu. A scholar is included among the top collaborators of Wilson Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilson Hu. Wilson Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Masárová, Lucia, John Mascarenhas, Raajit K. Rampal, et al.. (2024). Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety. Cancer. 131(1). e35661–e35661. 4 indexed citations
2.
Hu, Wilson, et al.. (2024). Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year. American Journal of Clinical Dermatology. 25(2). 327–332. 9 indexed citations
3.
Verstovšek, Srđan, Ruben A. Mesa, Robert A. Livingston, Wilson Hu, & John Mascarenhas. (2023). Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety. Journal of Hematology & Oncology. 16(1). 82–82. 24 indexed citations
4.
5.
Kanegane, Hirokazu, Kohsuke Imai, Masafumi Yamada, et al.. (2014). Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases. Journal of Clinical Immunology. 34(2). 204–211. 28 indexed citations
6.
Lambert, Stephen B., Michael D. Nissen, Terry Nolan, et al.. (2013). Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents. Influenza and Other Respiratory Viruses. 7(5). 676–685. 11 indexed citations
7.
Greenberg, Michael E., Michael H. Lai, Günter Härtel, et al.. (2009). Response to a Monovalent 2009 Influenza A (H1N1) Vaccine. New England Journal of Medicine. 361(25). 2405–2413. 403 indexed citations breakdown →
8.
Greenberg, Michael E., Michael H. Lai, Günter Härtel, et al.. (2009). Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine — Preliminary Report. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026